ITER study of patients with haemophilia A and factor VIII inhibitors

被引：0
|
作者：
Holstein, K. [1 ]
Klamroth, R. [2 ,3 ]
von Depka, M. [4 ]
Gringeri, A. [5 ,6 ]
Lambert, T. [7 ]
Lopez-Fernandez, M. [8 ]
Diniz, M. J. [9 ]
Rocino, A. [10 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, D-20246 Hamburg, Germany
[2] Vivantes Klinikum Friedrichshain, Innere Med Klin, Berlin, Germany
[3] Vivantes Klinikum Friedrichshain, Hamophiliezentrum, Berlin, Germany
[4] Werlhof Inst, Hannover, Germany
[5] Mangiagalli & Regina Elena Hosp Fdn, IRCCS Maggiore Policlin, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[6] Univ Milan, I-20122 Milan, Italy
[7] Hop Bicetre, AP HP, Ctr Traitement Hemophiles, Le Kremlin Bicetre, France
[8] Complexo Hosp Univ A Coruna, Serv Hematol & Hemotherapia, Thrombosis & Haemostasis Unit, La Coruna, Spain
[9] Hosp San Jose, Ctr Hosp Lisboa Cent, Serv Imuno Hemoterapia, Lisbon, Portugal
[10] San Giovanni Bosco Hosp, Hemophilia & Thrombosis Ctr, Naples, Italy
来源：
HAMOSTASEOLOGIE | 2010年 / 30卷 / 4A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S46 / S47
页数：2
相关论文
共 50 条
  • [1] Pathophysiology of inhibitors to factor VIII in patients with haemophilia A
    Lacroix-Desmazes, S
    Misra, N
    Bayry, J
    Artaud, C
    Drayton, B
    Kaveri, SV
    Kazatchkine, MD
    HAEMOPHILIA, 2002, 8 (03) : 273 - 279
  • [2] Immune tolerance outcome and economics retrospective registry (iter-study) of patients with haemophilia A (ha) and factor VIII inhibitors
    Rocino, A.
    Gringeri, A.
    Lambert, T.
    Klamroth, R.
    Lopez-Fernandez, F. M.
    Diniz, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 520 - 520
  • [3] Update on the immune tolerance and economics retrospective registry (ITER) of patients with haemophilia A (HA) and factor VIII inhibitors
    Gringeri, A.
    Rocino, A.
    Astermark, J.
    Diniz, M. J.
    Fijnvandraat, K.
    Klamroth, R.
    Lavigne-Lissalde, G.
    Lambert, T.
    Lopez-Fernandez, M. F.
    Morfini, M.
    Altisent, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 510 - 511
  • [4] The economic impact of factor VIII inhibitors in patients with haemophilia
    Bohn, RL
    Aledort, LM
    Putnam, KG
    Ewenstein, BM
    Mogun, H
    Avorn, J
    HAEMOPHILIA, 2004, 10 (01) : 63 - 68
  • [5] Factor VIII inhibitors in patients with moderate severity haemophilia A
    Hay, CRM
    Ludlam, CA
    Colvin, BT
    Hill, FGH
    Preston, FE
    Bunschotten, EP
    Finvandraat, K
    Sultan, Y
    White, G
    Kasper, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 229 - 229
  • [6] Development of factor VIII inhibitors in two patients with moderate haemophilia A
    Paschal, R. D.
    Meeks, S. L.
    Neff, A. T.
    HAEMOPHILIA, 2013, 19 (01) : E55 - E57
  • [7] Factor VIII inhibitors in haemophilia A patients after continuous infusion of factor VIII concentrates.
    von Auer, C
    Oldenburg, J
    Krause, M
    Miesbach, W
    Scharrer, I
    BLOOD, 2005, 106 (11) : 894A - 894A
  • [8] Hydrolysis of factor VIII mediated by catalytic antibodies occurs in haemophilia A patients with or without factor VIII inhibitors
    Grosbois, S. S.
    Brionne, M. F.
    Longcamp, A. L. F.
    Gautier, P.
    Kaveri, S. V.
    Borel-Derlon, A.
    Repesse, Y.
    HAEMOPHILIA, 2013, 19 (02) : 322 - 329
  • [9] Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors
    Batlle, J
    López, MF
    Brackmann, HH
    Gaillard, S
    Goudemand, J
    Humbert, J
    De Moerloose, P
    Maass, E
    Mauz-Körholz, C
    Sultan, Y
    Stieltjes, N
    HAEMOPHILIA, 1999, 5 (06) : 431 - 435
  • [10] Continuous infusion of porcine factor VIII in patients with haemophilia A and inhibitors.
    Hay, CRM
    BoltonMaggs, PBM
    Castaman, G
    Goldsmith, JC
    DiMichele, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 228 - 228
12345